Black Diamond Therapeutics Announces Financial Results and Strategic Updates for Q1 2025
May 12, 2025 - 22:08
In a recent corporate update, Black Diamond Therapeutics revealed significant advancements in its clinical trials and financial standing for the first quarter of 2025. The company is on track to present clinical data from its Phase 2 trial of BDTX-1535, targeting first-line patients with non-classical EGFR mutations in non-small cell lung cancer (NSCLC), with results expected in the fourth quarter of 2025.
Additionally, the company has initiated an expansion of its investigator-sponsored Phase 0/1 trial, focusing on newly diagnosed glioblastoma patients with EGFR alterations. This expansion commenced in the first quarter of 2025, reflecting the company’s commitment to exploring innovative treatment options for challenging cancers.
Financially, Black Diamond Therapeutics reported cash, cash equivalents, and investments totaling $152.4 million as of March 31, 2025. This financial position is anticipated to adequately support the company’s operations through to the fourth quarter of 2027, ensuring continued progress in its clinical and research endeavors.
MORE NEWS
February 20, 2026 - 21:54
Looking to leave? Savvy Ladies has free financial advice for women going through divorceNavigating the financial complexities of divorce can be a daunting barrier, particularly for women. A significant factor that keeps many in unhappy or even abusive situations is a fundamental lack...
February 20, 2026 - 12:06
Financial Hub 'Y'all Street' rises as Dallas delegation makes its case to NYC firmsA high-powered delegation from Dallas recently descended upon New York City with a clear mission: to lure financial firms and talent to the booming Texas metropolis. The campaign, informally...
February 19, 2026 - 23:54
Stock market today: Dow, S&P 500, Nasdaq slip as oil prices continue rally amid Iran-US tensionsU.S. stock markets opened lower on Monday, extending recent losses as a surge in oil prices and heightened Middle East tensions overshadowed corporate earnings reports. The Dow Jones Industrial...
February 19, 2026 - 06:53
Discovering Opportunities: AGTech Holdings And 2 Other Promising Asian Penny StocksAs Asian markets navigate a landscape marked by varying economic signals and investor sentiment, opportunities continue to emerge for those looking beyond traditional investments. Penny stocks,...